Cingulate Therapeutics LLC:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Cingulate Therapeutics LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11316
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:24
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Cingulate Therapeutics LLC (Cingulate) is a clinical stage biopharmaceutical company that develops new drug products for the treatment of attention deficit and hyperactivity disorder. The company’s pipeline products comprise CTX-1301 and CTX-1302 utilize precision timed release (PTR) drug delivery platform technology for treating attention deficit hyperactivity disorder. Its technology enables the formulation and manufacturing of multi-cored tablets. Cingulate’s products are used for the treatment of central nervous system and neurobiological disorders. The company operates through in Kansas City and Morristown. Cingulate is headquartered in Kansas City, Kansas, the US.

Cingulate Therapeutics LLC – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Cingulate Therapeutics LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Cingulate Therapeutics LLC, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Cingulate Therapeutics LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Cingulate Therapeutics LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Cingulate Therapeutics LLC, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Cingulate Therapeutics LLC, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Cingulate Therapeutics Raises US$0.08 Million In Venture Financing 10
Cingulate Therapeutics Raises USD15.6 Million in Venture Financing 11
Private Equity 12
Werth Family Investment Associates Invests USD7.5 Million in Cingulate Therapeutics 12
Licensing Agreements 13
Bio-Images Drug Delivery Enters into Licensing Agreement with Cingulate Therapeutics 13
Catalent Pharma Enters into Licensing Agreement with Cingulate Therapeutics for CTX-1301 and CTX-1302 14
Cingulate Therapeutics LLC – Key Competitors 15
Cingulate Therapeutics LLC – Key Employees 16
Cingulate Therapeutics LLC – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Recent Developments 18
Corporate Communications 18
May 31, 2018: Cingulate Therapeutics Strengthens Leadership with Two New Board Appointments 18
Apr 02, 2018: Cingulate Therapeutics Appoints Laurie Myers, PhD, MBA as Chief Operating Officer 19
Jan 09, 2018: Cingulate Therapeutics Appoints Experienced Lead Investigator Matthew Brams, MD as Chief Medical Officer 20
Jul 10, 2017: Cingulate Therapeutics Appoints Strategic Finance Veteran Louis G. Van Horn as Chief Financial Officer 21
Product News 22
05/31/2017: Cingulate Therapeutics Initiates First Human Clinical Trial 22
Other Significant Developments 23
Jun 15, 2017: Cingulate Therapeutics Announces Expansion to Accommodate Growth 23
Appendix 24
Methodology 24
About GlobalData 24
Contact Us 24
Disclaimer 24

List of Tables
Cingulate Therapeutics LLC, Pharmaceuticals & Healthcare, Key Facts 2
Cingulate Therapeutics LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Cingulate Therapeutics LLC, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Cingulate Therapeutics LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Cingulate Therapeutics LLC, Deals By Therapy Area, 2012 to YTD 2018 8
Cingulate Therapeutics LLC, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Cingulate Therapeutics Raises US$0.08 Million In Venture Financing 10
Cingulate Therapeutics Raises USD15.6 Million in Venture Financing 11
Werth Family Investment Associates Invests USD7.5 Million in Cingulate Therapeutics 12
Bio-Images Drug Delivery Enters into Licensing Agreement with Cingulate Therapeutics 13
Catalent Pharma Enters into Licensing Agreement with Cingulate Therapeutics for CTX-1301 and CTX-1302 14
Cingulate Therapeutics LLC, Key Competitors 15
Cingulate Therapeutics LLC, Key Employees 16
Cingulate Therapeutics LLC, Other Locations 17

List of Figures
Cingulate Therapeutics LLC, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Cingulate Therapeutics LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Cingulate Therapeutics LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Cingulate Therapeutics LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Cingulate Therapeutics LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Cingulate Therapeutics LLC, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Cingulate Therapeutics LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Cingulate Therapeutics LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Cingulate Therapeutics LLC:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Indian Oil Corporation Limited:企業の戦略・SWOT・財務分析
    Indian Oil Corporation Limited - Strategy, SWOT and Corporate Finance Report Summary Indian Oil Corporation Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Osprey Medical Inc (OSP):企業の財務・戦略的SWOT分析
    Summary Osprey Medical Inc (Osprey Medical) is a medical device company that designs, develops, and manufacturers proprietary devices and monitoring systems. The company offers contrast removal system, which is designed to provide cardiologists with an advanced level of CIN protection in high risk p …
  • Shandong Airlines Co., Ltd.:企業の戦略・SWOT・財務分析
    Shandong Airlines Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Shandong Airlines Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Spark New Zealand Ltd:企業の戦略・SWOT・財務分析
    Spark New Zealand Ltd - Strategy, SWOT and Corporate Finance Report Summary Spark New Zealand Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Symphony Ltd:企業の戦略・SWOT・財務情報
    Symphony Ltd - Strategy, SWOT and Corporate Finance Report Summary Symphony Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Tessa Therapeutics Pte Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Tessa Therapeutics Pte Ltd (Tessa Therapeutics) is a clinical-stage biotechnology company that develops and commercializes cancer immunotherapies that redirect the body’s powerful anti-viral immune response to identify and exterminate cancer cells. The company provides products for various c …
  • Constellation Brands Inc (STZ):企業の財務・戦略的SWOT分析
    Constellation Brands Inc (STZ) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • The Federal Bank Limited:企業の戦略・SWOT・財務分析
    The Federal Bank Limited - Strategy, SWOT and Corporate Finance Report Summary The Federal Bank Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • M. A. Mortenson Co:戦略・SWOT・企業財務分析
    M. A. Mortenson Co - Strategy, SWOT and Corporate Finance Report Summary M. A. Mortenson Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Thomas Cook (India) Limited
    Thomas Cook (India) Limited - Strategy, SWOT and Corporate Finance Report Summary Thomas Cook (India) Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Holly Energy Partners LP:企業のM&A・事業提携・投資動向
    Holly Energy Partners LP - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Holly Energy Partners LP Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisiti …
  • TenneT Holding BV:企業の戦略的SWOT分析
    TenneT Holding BV - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Veryan Medical Ltd:医療機器:M&Aディール及び事業提携情報
    Summary Veryan Medical Ltd (Veryan), a subsidiary of Veryan Holdings Ltd, is a medical device company that designs and develops vascular biomimetic stents. It develops BioMimics 3D stent, a peripheral self-expanding nickel-titanium alloy (Nitinol) stent with unique three-dimensional helical centreli …
  • CapeRay Medical (Pty) Ltd:製品パイプライン分析
    Summary CapeRay Medical (Pty) Ltd (CapeRay), formerly African Medical Imaging is a medical device company that offers imaging solutions. The company offers breast imaging devices. It offers aceso system to detect breast cancer with standard digital mammography. CapeRay’s aceso system is used for det …
  • America Movil, SA DE C.V.:戦略・SWOT・企業財務分析
    America Movil, SA DE C.V. - Strategy, SWOT and Corporate Finance Report Summary America Movil, SA DE C.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Xi’An Catering Co., Ltd.:企業の戦略・SWOT・財務分析
    Xi'An Catering Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Xi'An Catering Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Novacyt SA (ALNOV):企業の財務・戦略的SWOT分析
    Summary Novacyt SA (Novacyt) is a medical device company that develops and markets medical cytology solutions. The company offers oncology and infectious disease diagnostic products. It also sells diagnostic reagents used in LBC, oncology, microbiology, haematology and serology testing. Novacyt deve …
  • Far Eastone Telecommunications Co Ltd (4904):企業の財務・戦略的SWOT分析
    Far Eastone Telecommunications Co Ltd (4904) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stren …
  • HomeWorks Tri-County Electric Cooperative Inc:企業の戦略的SWOT分析
    HomeWorks Tri-County Electric Cooperative Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors …
  • Banque Cantonale de Geneve Private Banking:企業の戦略・SWOT・財務分析
    Banque Cantonale de Geneve Private Banking - Strategy, SWOT and Corporate Finance Report Summary Banque Cantonale de Geneve Private Banking - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆